This article was originally published here

Int J Mol Sci. 2021 Aug 5;22(16):8395. doi: 10.3390/ijms22168395.

ABSTRACT

The current coronavirus disease-19 (COVID-19) pandemic has strongly revived the pressing need to incorporate new therapeutic alternatives to deal with medical situations that result in a dramatic breakdown in the bodys normal homeostasis [].

PMID:34445102 | DOI:10.3390/ijms22168395

View original post here:

Mesenchymal Stem/Stromal Cells and Their Derivates in Acute Diseases: Emergency in the Post-COVID-19 Times - DocWire News

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh